Clinical Site

The Bronx, New York 10467

2 studies enrolling now · 3 studies all time

What they study most

Hidradenitis Suppurativa, Non-Small Cell Lung Cancer

Studies at this site

• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
• A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa — Enrolling by invitation